Dividends & Buybacks ·
Novo Nordisk repurchases DKK 1.84B of shares in September and early October
NONOFNovo Nordisk A S
Novo Nordisk reported additional share repurchases totaling approximately DKK 1.84 billion between late September and early October 2026, bringing the cumulative spend under its current programme to over DKK 6.44 billion. Since February 2026, the company has acquired a total of 36.6 million B shares at an average price of DKK 279.95 per share, representing roughly 1.1% of its outstanding capital. Novo Nordisk is a global healthcare company focused on developing treatments for diabetes and obesity.